Laminin-γ2 overexpression in head-and-neck squamous cell carcinoma

被引:40
|
作者
Patel, V
Aldridge, K
Ensley, JF
Odell, E
Boyd, A
Jones, J
Gutkind, JS
Yeudall, WA
机构
[1] Kings Coll London, GKT Dent Inst, Head & Neck Canc Program, London SE1 9RT, England
[2] NIDCR, Oral & Pharyngeal Canc Branch, Bethesda, MD USA
[3] Wayne State Univ, Div Hematol Oncol, Detroit, MI USA
关键词
laminin; oral cancer; differential display; tumor progression; biomarker;
D O I
10.1002/ijc.10403
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To identify molecular markers for the progression of head-and-neck squamous cell carcinoma (HNSCC), we used RNA arbitrarily primed (RAP) PCR to determine the qualitative and quantitative differences in gene expression between normal epithelial cells, those derived from dysplastic oral mucosa and invasive and metastatic HNSCC. Three differentially expressed DNA fragments (RAP20, RAP21, RAP26) that were upregulated in a tumor cell line (T45) were identified as being regions of the gamma2 subunit of human laminin-5. Northern blot analysis of total cellular RNA revealed overexpression of these transcripts in 6 of 7 HNSCC cell lines compared with normal epidermal keratinocytes. In contrast, no differences were observed in HeLa (cervical carcinoma) or HCT 116 (colon carcinoma) cells. Immunostaining of HNSCC cells derived from primary (HN4) and metastatic (HN12) tumors indicated elevated levels of endogenous laminin-gamma2 protein. Furthermore, HNSCC tissues demonstrated strong laminin-gamma2 staining, particularly in the peripheral basaloid cells of tumor islands at the invasion front. In contrast, only minimal staining of laminin-gamma2 was detected in basal cells of the normal epithelium. The data indicate that laminin-gamma2 is frequently overexpressed in HNSCCs and derivative cell lines and that its overexpression is likely to be useful as a marker of head-and-neck squamous malignancy. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:583 / 588
页数:6
相关论文
共 50 条
  • [1] Afatinib activity against head-and-neck or esophageal squamous cell carcinoma: Significance of activating oncogenic HER4 mutations in head-and-neck squamous cell carcinoma
    Togashi, Y.
    Nakamura, Y.
    Tomida, S.
    Hayashi, H.
    de Velasco, M. A.
    Sakai, K.
    Fujita, Y.
    Hamada, S.
    Nishio, K.
    ANNALS OF ONCOLOGY, 2015, 26 : 97 - 97
  • [2] Serum concentrations of laminin γ2 fragments in patients with head and neck squamous cell carcinoma
    Kuratomi, Yuichiro
    Sato, Shintaro
    Monji, Mikio
    Shimazu, Rintaro
    Tanaka, Gou
    Yokogawa, Kyoko
    Inoue, Akiko
    Inokuchi, Akira
    Katayama, Masahiko
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (08): : 1058 - 1063
  • [3] Phase 2 Trial of AT-101 in Combination With Docetaxel for Recurrent, Locally Advanced, or Metastatic Head-and-Neck Squamous Cell Carcinoma (HNSCC) Management of Recurrent Head-and-Neck Squamous Cell Carcinoma
    Sacco, A.
    Nor, J.
    Belile, E.
    Sukari, A.
    Chepeha, D.
    Bradford, C.
    Eisbruch, A.
    Wolf, G.
    Urba, S.
    Worden, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 507 - 507
  • [4] Palliative Radiotherapy for Cutaneous Squamous Cell Carcinoma of the Head-and-Neck Region
    Staackmann, Christian
    Schild, Steven E.
    Rades, Dirk
    IN VIVO, 2021, 35 (04): : 2283 - 2288
  • [5] Prognosis classifier for elderly head-and-neck squamous cell carcinoma patients
    Ruehle, A.
    Stromberger, C.
    Haehl, E.
    Senger, C.
    Falkenstein, A. E.
    Stoian, R.
    Zamboglou, C.
    Knopf, A.
    Grosu, A.
    Nicolay, N.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S843 - S843
  • [6] Effectiveness of head-and-neck molecular imaging reporting and data system criterion in head-and-neck squamous cell carcinoma postconcurrent chemoradiotherapy
    Gupta, Manoj
    Jajodia, Ankush
    Ahlawat, Parveen
    Gairola, Munish
    Agarwal, Mudit
    Goyal, Sumit
    Mehta, Parv
    Choudhury, Partha
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2023, 38 (04): : 334 - 339
  • [7] Patterns of Failure in Patients With Head-and-Neck Carcinoma of Unknown Primary Treated With Radiation Therapy Definitive Management of Head-and-Neck Squamous Cell Carcinoma
    Cuaron, J.
    Rao, S.
    Wolden, S.
    Zelefsky, M.
    Schupak, K.
    Mychalczak, B.
    Lee, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 479 - 479
  • [8] Chemoradiation in older head-and-neck squamous cell carcinoma patients - A multicenter analysis
    Ruehle, A.
    Marschner, S.
    Haderlein, M.
    Fabian, A.
    Senger, C.
    Dickstein, D. R.
    Kraft, J.
    Gruen, J. V. D.
    Chen, E.
    Aquino-Michaels, T.
    Domschikowski, J.
    Bickel, A.
    Altay-Langguth, A.
    Lewitzki, V.
    Ferentinos, K.
    Schnellhardt, S.
    Guckenberger, M.
    Budach, V.
    Belka, C.
    Bakst, R.
    Mayer, A.
    Grosu, A.
    Balermpas, P.
    Stromberger, C.
    Nicolay, N. H.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S589 - S589
  • [9] Localization of annexin Al in normal epithelium and head-and-neck squamous cell carcinoma
    Pena, E
    García, J
    Rodrigo, JP
    Fernández, P
    González, MV
    Gutiérrez, C
    FEBS JOURNAL, 2005, 272 : 444 - 444
  • [10] Overexpression of the Hedgehog Signalling Pathway in Head and Neck Squamous Cell Carcinoma
    Dimitrova, Kamelia
    Stoehr, Matthaeus
    Dehghani, Faramarz
    Dietz, Andreas
    Wichmann, Gunnar
    Bertolinic, Julia
    Mozet, Christian
    ONKOLOGIE, 2013, 36 (05): : 279 - +